Search research articles
Contact Us
Filters
Showing results (121-130 of 145) with videos related to
Page
of 15
Sort By:
Future Oncology (London, England)
|
August 19, 2024
TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer
Rayan Kabirian, Olivier Tredan, Frederik Marmé, et al.
Gynecologic Oncology
|
June 26, 2026
Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network
Thomas Montassier, Enora Laas, Judicael Hotton, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 17, 2024
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART
Birgit Geoerger, Francisco Bautista, Nicolas André, et al.
JAMA Network Open
|
January 11, 2020
Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis
Xavier Paoletti, Liz-Anne Lewsley, Gennaro Daniele, et al.
JNCI Cancer Spectrum
|
February 19, 2021
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
Clémence Basse, Sarah Diakite, Vincent Servois, et al.
BMJ Open
|
June 17, 2026
HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency (HORNbILL): study protocol for a multicentre randomised placebo-controlled trial
Nicholas Heming, Elodie Baron, Grégoire Muller, et al.
Journal of the National Cancer Institute
|
October 11, 2013
Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis
Xavier Paoletti, Koji Oba, Yung-Jue Bang, et al.
The Lancet. Oncology
|
September 7, 2015
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalves, et al.
World Journal of Urology
|
July 22, 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial
Thierry Lebret, Xavier Paoletti, Geraldine Pignot, et al.
Nature Medicine
|
October 19, 2023
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial
Birgit Geoerger, Xavier Paoletti, Francisco Bautista, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 145) with videos related to
Sort By:
Page
of 15
Future Oncology (London, England)
|
August 19, 2024
TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer
Rayan Kabirian, Olivier Tredan, Frederik Marmé, et al.
Gynecologic Oncology
|
June 26, 2026
Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network
Thomas Montassier, Enora Laas, Judicael Hotton, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 17, 2024
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART
Birgit Geoerger, Francisco Bautista, Nicolas André, et al.
JAMA Network Open
|
January 11, 2020
Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis
Xavier Paoletti, Liz-Anne Lewsley, Gennaro Daniele, et al.
JNCI Cancer Spectrum
|
February 19, 2021
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
Clémence Basse, Sarah Diakite, Vincent Servois, et al.
BMJ Open
|
June 17, 2026
HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency (HORNbILL): study protocol for a multicentre randomised placebo-controlled trial
Nicholas Heming, Elodie Baron, Grégoire Muller, et al.
Journal of the National Cancer Institute
|
October 11, 2013
Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis
Xavier Paoletti, Koji Oba, Yung-Jue Bang, et al.
The Lancet. Oncology
|
September 7, 2015
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalves, et al.
World Journal of Urology
|
July 22, 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial
Thierry Lebret, Xavier Paoletti, Geraldine Pignot, et al.
Nature Medicine
|
October 19, 2023
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial
Birgit Geoerger, Xavier Paoletti, Francisco Bautista, et al.
Page
of 15